Table I.
Characteristic | n | % |
---|---|---|
Gender | ||
Male | 46 | 75.4 |
Female | 15 | 24.6 |
Age at diagnosis, years | ||
Median (range) | 61.6 (39.8–78.1) | |
Mean | 62.5 | |
Smoking history | ||
Smoker | 54 | 88.5 |
Non-smoker | 7 | 11.5 |
Histology | ||
Squamous cell carcinoma | 25 | 41.0 |
Adenocarcinoma | 28 | 45.9 |
Large cell carcinoma | 8 | 13.1 |
Tumor size, T | ||
T1a | 6 | 9.8 |
T1b | 7 | 11.5 |
T2a | 26 | 42.6 |
T2b | 10 | 16.4 |
T3 | 12 | 19.7 |
Lymph node status, N | ||
N0 | 45 | 73.8 |
N1 | 16 | 26.2 |
Tumor stage | ||
IA (I) | 11 | 18.0 |
IB (II) | 19 | 31.2 |
IIA (III) | 11 | 18.0 |
IIB (IV) | 20 | 32.8 |
Follow-up period, months | ||
Median | 49 | |
Range | 5–86 | |
Status | ||
Alive/censored | 33 | 54.1 |
Succumbed to lung cancer | 27 | 44.3 |
Other cause of mortality | 1 | 1.6 |
Relapse-free survival time, months | ||
Median | 47 | |
Range | 3–86 |